UK’s competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific’s $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
July 8, 2024 - 14:34
By Pharos Investment Advisors Comments are Off
UK’s competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific’s $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved